小体素PSF重建优化分化型甲状腺癌头颈18FDG PET/CT协议
本研究在21例碘难治性分化或低分化甲状腺癌(DTC/PDTC)患者中,比较3D-OSEM与无后滤波PSF(PSFallpass)重建,并模拟每床位2至10分钟采集时间。结果显示PSFallpass较3D-OSEM检出更多恶性病灶,且每床位8至10分钟采集性能最佳。
要点
- PSFallpass重建较3D-OSEM显著提高头颈18FDG PET恶性病灶检出率。
- PSFallpass每床位采集8至10分钟时肿瘤检出性能最佳。
- PSFallpass在8和10分钟可显示比3D-OSEM更小的恶性淋巴结。
核心结论
- PSFallpass头颈PET较3D-OSEM头颈PET改善病灶可检测性。
- PSFallpass每床位采集8至10分钟为肿瘤检测提供最佳性能。
研究设计与样本
- 连续纳入21例DTC/PDTC患者,采用列表模式行头颈PET/CT采集。
- 重建模拟每床位2至10分钟共五种采集时间,分别用3D-OSEM或PSFallpass重建,生成210个匿名数据集随机评估。
- 以5分量表评估颈部淋巴结或甲状腺床18FDG摄取,并记录噪声、SUVmax、肿瘤/本底比及CT病灶尺寸。
- 手术患者由病理学家测量每个淋巴结转移灶最大肿瘤尺寸。
- 12例至少1个18FDG焦点评为恶性的患者共120个头颈PET研究构成研究组。
主要发现
- 3D-OSEM和PSFallpass重建噪声水平在2至4分钟之间均显著下降(p < 0.01)。
- 3D-OSEM和PSFallpass重建的肿瘤/本底比在所有采集时间相似(分别为p = 0.25和p = 0.44)。
- PSFallpass重建恶性焦点检出率从2分钟至10分钟显著提高(20/26至26/26;p = 0.01),3D-OSEM无显著提高(15/26至19/26;p = 0.26)。
- 五个采集时间中,PSFallpass均较3D-OSEM检出更多恶性焦点(p < 0.01)。
- 7例手术患者中,PSFallpass在8和10分钟显示比3D-OSEM更小的恶性淋巴结。
临床怎么用
- 对碘难治性DTC/PDTC患者行头颈18FDG PET/CT时,可优先采用无后滤波PSF重建以提高小病灶检出。
- 建议头颈PET每床位采集时间设为8至10分钟以优化肿瘤检测性能。
局限性
- 研究仅纳入21例患者,其中12例构成研究组,样本量有限。
- 研究仅比较3D-OSEM与PSFallpass两种重建算法,未涉及其他重建参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: 18FDG PET/CT is crucial before neck surgery for nodal recurrence localization in iodine-refractory differentiated or poorly differentiated thyroid cancer (DTC/PDTC). A dedicated head-and-neck (HN) acquisition performed with a thin matrix and point-spread-function (PSF) modelling in addition to the whole-body PET study has been shown to improve the detection of small cancer deposits. Different protocols have been reported with various acquisition times of HN PET/CT. We aimed to compare two reconstruction algorithms for disease detection and to determine the optimal acquisition time per bed position using the Siemens Biograph6 with extended field-of-view. METHODS: Twenty-one consecutive and unselected patients with DTC/PDTC underwent HN PET/CT acquisition using list-mode. PET data were reconstructed, mimicking five different acquisition times per bed position from 2 to 10 min. Each PET data set was reconstructed using 3D-ordered subset expectation maximisation (3D-OSEM) or iterative reconstruction with PSF modelling with no post filtering (PSFallpass). These reconstructions resulted in 210 anonymized datasets that were randomly reviewed to assess 18FDG uptake in cervical lymph nodes or in the thyroid bed using a 5-point scale. Noise level, maximal standard uptake values (SUVmax), tumour/background ratios (TBRs) and dimensions of the corresponding lesion on the CT scan were recorded. In surgical patients, the largest tumoral size of each lymph node metastasis was measured by a pathologist. RESULTS: The 120 HN PET studies of the 12 patients with at least 1 18FDG focus scored malignant formed the study group. Noise level significantly decreased between 2 and 4 min for both 3D-OSEM and PSFallpass reconstructions (p < 0.01). TBRs were similar for all the acquisition times for both 3D-OSEM and PSFallpass reconstructions (p = 0.25 and 0.44, respectively). The detection rate of malignant foci significantly improved from 2 to 10 min for PSFallpass reconstruction (20/26 to 26/26; p = 0.01) but not for 3D-OSEM (15/26 to 19/26; p = 0.26). For each of the five acquisition times, PSFallpass detected more malignant foci than 3D-OSEM (p < 0.01). In the seven surgical patients, PSFallpass evidenced smaller malignant lymph nodes than 3D-OSEM at 8 and 10 min. At 10 min, the mean size of the lymph node metastases neither detected with PSFallpass nor 3D-OSEM was 3 ± 0.6 mm vs 5.8 ± 1.1 mm for those detected with PSFallpass only and 10.9 ± 3.3 for those detected with both reconstructions (p < 0.001). CONCLUSIONS: PSFallpass HN PET improves lesion detectability as compared with 3D-OSEM HN PET. PSFallpass with an acquisition time between 8 and 10 min provides the best performance for tumour detection.
引用
- Ciappuccini R, Desmonts C, Licaj I, et al. Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck 18FDG PET/CT imaging in differentiated thyroid cancer. EJNMMI Res. 2018. PMID: 30511173. doi:10.1186/s13550-018-0461-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。